Peresolimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peresolimab, covering 2025-12-04 to 2025-12-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis [Phase 2]